Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study

被引：0

作者：

Ali Ahmadi

Majid Shirani

Arsalan Khaledifar

Morteza Hashemzadeh

Kamal Solati

Soleiman Kheiri

Mehraban Sadeghi

Abdollah Mohammadian-Hafshejani

Hadi Raeisi Shahraki

Alireza Asgharzadeh

Ali Zamen Salehifard

Masoumeh Mousavi

Elaheh Zarean

Reza Goujani

Seyed Saeed Hashemi Nazari

Hossein Poustchi

Pierre-Antoine Dugué

机构：

[1] Shahrekord University of Medical Sciences,Modeling in Health Research Center

[2] Shahrekord University of Medical Sciences,Department of Epidemiology and Biostatistics, School of Public Health

[3] Shahrekord University of Medical Sciences,Department of Urology

[4] Shahrekord University of Medical Sciences,Department of Cardiology, School of Medicine

[5] Shahrekord University of Medical Sciences,Cellular and Molecular Research Center

[6] Shahrekord University of Medical Sciences,Department of Psychiatry

[7] Shahrekord University of Medical Sciences,Department of Environmental Engineering, School of Public Health

[8] Shahrekord University of Medical Sciences,School of Medicine

[9] Shahid Beheshti University of Medical Sciences,Safety Promotion and Injury Prevention Research Center, Department of Epidemiology, School of Public Health and Safety

[10] Tehran University of Medical Sciences,Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute

[11] Monash University,Precision Medicine, School of Clinical Sciences at Monash Health

[12] Cancer Epidemiology Division,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health

[13] Cancer Council Victoria,undefined

[14] The University of Melbourne,undefined

来源：

BMC Public Health | / 21卷

关键词：

Cohort; Non-communicable diseases; Risk factors; Multimorbidity; PERSIAN;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 106 条

[1]

Bakhtiari A(2019)Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study JAMA Oncol 5 1749-1768

[2]

Takian A(2020)Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran BMC Public Health 20 333-616

[3]

Majdzadeh R(2017)Protocol design for large–scale cross-sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016 Arch Iran Med 20 608-512

[4]

Haghdoost AA(2017)National action plan for non-communicable disease prevention and control in Iran; a response to the emerging epidemic J Diabetes Metab Disord 16 3-2005

[5]

Djalalinia S(2013)The World Health Assembly responds to the global challenge of non-communicable diseases East Mediterr Health J 19 511-59

[6]

Modirian M(2019)Iran in transition Lancet. 393 1984-1400

[7]

Sheidaei A(2010)Cohort profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in Northern Iran Int J Epidemiol 39 52-698

[8]

Peykari N(2014)Cohort profile: The Amirkola Health and Ageing Project (AHAP) Int J Epidemiol 43 1393-655

[9]

Hashemi H(2018)Cohort Profile: The Yazd Health Study (YaHS): a population-based study of adults aged 20–70 years (study design and baseline population data) Int J Epidemiol 47 697-683

[10]

Dinarvand R(2018)Review of rationale, design, and initial findings: Tehran Lipid and Glucose Study Int J Endocrinol Metab 16 84777-285

← 1 2 3 4 5 6 7 8 9 10 →